(Q46782202)

25 December 2017

title

Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up (English)

1 reference

25 December 2017

1 reference

1 reference

1

1 reference

25 December 2017

author name string

Kröger N

2

1 reference

25 December 2017

Zabelina T

3

1 reference

25 December 2017

Ayuk F

4

1 reference

25 December 2017

Schieder H

5

1 reference

25 December 2017

Renges H

6

1 reference

25 December 2017

Fehse N

7

1 reference

25 December 2017

Waschke O

8

1 reference

25 December 2017

Fehse B

9

1 reference

25 December 2017

Kabisch H

10

1 reference

25 December 2017

Zander AR

11

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

25 December 2017

Bone Marrow Transplantation

published in

1 reference

25 December 2017

volume

37

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

45-50

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705207

exact match

0 references

cites work

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

How I treat chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leuk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Autologous bone marrow transplantation in patients with adult acute leukemia in relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Autologous bone-marrow transplantation in relapsed adult acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705207

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705207

1 reference

25 December 2017

PubMed ID

16258531

1 reference

25 December 2017